Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction

2000 ◽  
Vol 140 (2) ◽  
pp. 324-328 ◽  
Author(s):  
Haruo Tomoda ◽  
Naoto Aoki
2000 ◽  
Vol 86 (1) ◽  
pp. 83-86 ◽  
Author(s):  
Masami Kosuge ◽  
Kazuo Kimura ◽  
Toshiyuki Ishikawa ◽  
Tsutomu Endo ◽  
Tomohiko Shigemasa ◽  
...  

2012 ◽  
Vol 31 (2) ◽  
pp. 131-134
Author(s):  
Shifang Ding ◽  
Yi Peng ◽  
Zhinan Chen ◽  
Juquan Jiang ◽  
Zhigang Gong ◽  
...  

Prognostic Value of High-Sensitivity C-Reactive Protein and Lipoprotein (a) in Acute Myocardial Infarction Patients Receiving Emergency Percutaneous Coronary InterventionIn order to study the prognostic value of high-sensitivity C-reactive protein (hsCRP) and lipoprotein (a) [Lp(a)] in patients receiving emergency percutaneous coronary intervention (PCI) following acute myocardial infarction (AMI), we retrospectively reviewed 118 patients who received emergency PCI following AMI from January 2007 to April 2010. The plasma levels of hsCRP and Lp(a) were determined. The incidence of cardiovascular events was compared between patients with an elevated hsCRP level and those with a normal hsCRP level and between patients with an elevated Lp(a) level and those with a normal Lp(a) level. Results showed that the incidence of cardiovascular events was 52.9% in the hsCRP-elevated group and 18.2% in the hsCRP-normal group displaying a significant difference (P=0.011). However, the incidence of cardiovascular events was 35.3% in the Lp(a)-elevated group and 46.4% in the Lp(a)-normal group and statistical analysis revealed no significant difference (P=0.733). HsCRP, but not Lp(a), can serve as a prognostic factor for patients receiving emergency PCI following AMI.


2002 ◽  
Vol 144 (5) ◽  
pp. 782-789 ◽  
Author(s):  
Michael N. Zairis ◽  
Stavros J. Manousakis ◽  
Alexander S. Stefanidis ◽  
Olga A. Papadaki ◽  
George K. Andrikopoulos ◽  
...  

2003 ◽  
Vol 41 (6) ◽  
pp. 340
Author(s):  
Mahmoud A. Suleiman ◽  
Doron Aronson ◽  
Michael Kapeliovich ◽  
Arthour Kerner ◽  
Yishai Levy ◽  
...  

Angiology ◽  
2016 ◽  
Vol 68 (4) ◽  
pp. 354-359 ◽  
Author(s):  
Chong-Rong Qiu ◽  
Qiang Fu ◽  
Jian Sui ◽  
Qian Zhang ◽  
Peng Wei ◽  
...  

Endothelial dysfunction is involved in the process of acute myocardial infarction (AMI), that is, the endothelial cell–specific molecule 1 (ESM-1; endocan) is a novel endothelial dysfunction marker. However, the relationship between patients with AMI and serum ESM-1 levels is not very clear. Patients with AMI (n = 216) and a control group (n = 60) without AMI were included in the study. High-sensitivity C-reactive protein (hsCRP) was measured, and the severity of AMI was assessed by a modified Gensini stenosis scoring system. Serum ESM-1 levels were significantly higher in the AMI group ( P < .05). High-sensitivity C-reactive protein levels were also significantly higher in the AMI group ( P < .05). In patients with AMI, serum ESM-1 levels were not significantly correlated with hsCRP levels. There was no significant correlation between serum ESM-1 level and Gensini score. Our findings suggest that serum ESM-1 levels may be a novel biomarker of endothelial dysfunction in patients with AMI.


2004 ◽  
Vol 147 (6) ◽  
pp. 1005-1009 ◽  
Author(s):  
Efthymios N Deliargyris ◽  
Phoebus N Madianos ◽  
Waka Kadoma ◽  
Irene Marron ◽  
Sidney C Smith ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document